Important aim of the study is to investigate, aspects related to effectiveness, safety and tolerability at 3 months' lurasidone treatment in a routine practice in Italian clinical settings.
Only patients with primary diagnosis of schizophrenia who are prescribed lurasidone was evaluated for inclusion in the study.
